Skip to content

Nuvation Bio NUVB Interest Paid

Interest Paid at other companies

Pfizer logo
PfizerPFE
$293M-17.0%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$2.78M+114%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$1.75M+600%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$0
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$20.12M+29.0%
Roivant Sciences logo
Roivant SciencesROIV
$0-100%

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.25B+150%
Enterprise value$2.18B+154%
P/S15.7×-66.3×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Nuvation Bio’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's interest paid?
Nuvation Bio (NUVB) reported interest paid of $720.5K in Q4 2025.
How has Nuvation Bio's interest paid changed year-over-year?
Nuvation Bio's interest paid increased by 745.2% year-over-year, from $85.25K to $720.5K.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.